Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1J H Cho, D L Nicolae, L H Gold, et al.
The Journal of Trauma and Acute Care Surgery|May 20, 2024
Platelet releasates mitigate the endotheliopathy of traumaLauren T Gallagher, Ian LaCroix, Alexander T Fields, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2022
COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" PerspectiveJérémie Joffre, Lauren Rodriguez, Zachary A Matthay, et al.
Annals of Internal Medicine|January 1, 1983
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal studyW E Dismukes, A M Stamm, J R Graybill, et al.
Trials|January 23, 2021
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasiaT Fields, M Patterson, T Bremova-Ertl, et al.
Frontiers in Immunology|March 31, 2023
Effects of the circulating environment of COVID-19 on platelet and neutrophil behaviorAlexander T Fields, Elizabeth A Andraska, Christof Kaltenmeier, et al.
Blood|November 22, 2024
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19Wen Zhu, Yongwei Zheng, Mei Yu, et al.
Practical Radiation Oncology|December 3, 2019
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons LearnedX Allen Li, Jennifer Moughan, Julia R White, et al.
Science Advances|September 13, 2021
Platelets amplify endotheliopathy in COVID-19Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Nature Communications|January 11, 2024
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial resultsGail D Lewis, Guangmin Li, Jun Guo, et al.
Pageof 11